Role of polycomb group proteins in stem cell self-renewal and cancer

DNA and Cell Biology

Volumn 24, Issue 2, 2005, Pages 117-125

  Gil, Jesús ^a   Bernard, David ^b   Peters, Gordon ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; HISTONE; POLYCOMB GROUP PROTEIN; PROTEIN; PROTEIN BMI1; PROTEIN CBX2; PROTEIN CBX4; PROTEIN CBX6; PROTEIN CBX7; PROTEIN EDR2; PROTEIN EDR3; PROTEIN EZH1; PROTEIN EZH2; PROTEIN NSPC1; PROTEIN RAE28; PROTEIN RING1A; PROTEIN RING1B; PROTEIN RNF110; PROTEIN RNF134; PROTEIN RNF159; PROTEIN RNF3; PROTEIN SUZ12; UNCLASSIFIED DRUG;

CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSFORMATION; GENE CONTROL; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STEM CELL;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; REPRESSOR PROTEINS; STEM CELLS;

EID: 13244279419     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.117     Document Type: Review

References (91)

1. ABDUL MOTALEB, M., TAKIHARA, Y., NOMURA, M., MATSUDA, Y., HIGASHINAKAGAWA, T., and SHIMADA, K. (1996). Structural organization of the rae28 gene, a putative murine homologue of the Drosophila polyhomeotic gene. J. Biochem. (Tokyo) 120, 797-802.
2. AKASAKA, T., KANNO, M., BALLING, R., MIEZA, M.A., TANIGUCHI, M., and KOSEKI, H. (1996). A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development 122, 1513-1522.
3. AKASAKA, T., VAN LOHUIZEN, M., VAN DER LUGT, N., MIZUTANI-KOSEKI, Y., KANNO, M., TANIGUCHI, M., VIDAL, M., ALKEMA, M., BERNS, A., and KOSEKI, H. (2001). Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development 128, 1587-1597.
4. ALKEMA, M.J., JACOBS, H., VAN LOHUIZEN, M., and BERNS, A. (1997). Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene 15, 899-910.
5. BEA, S., TORT, F., PINYOL, M., PUIG, X., HERNANDEZ, L., HERNANDEZ, S., FERNANDEZ, P.L., VAN LOHUIZEN, M., COLOMER, D., and CAMPO, E. (2001). BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61, 2409-2412.
6. BIRVE, A., SENGUPTA, A.K., BEUCHLE, D., LARSSON, J., KENNISON, J.A., RASMUSON-LESTANDER, A., and MULLER, J. (2001). Su(z)12, a novel Drosophila Polycomb group gene that is conserved in vertebrates and plants. Development 128, 3371-3379.
7. BRACKEN, A.P., PASINI, D., CAPRA, M., PROSPERINI, E., COLLI, E., and HELIN, K. (2003). EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323-5335.
8. CAO, R., WANG, L., WANG, H., XIA, L., ERDJUMENT-BROMAGE, H., TEMPST, P., JONES, R.S., and ZHANG, Y. (2002). Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039-1043.
9. CAO, R., and ZHANG, Y. (2004). SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15, 57-67.
10. CORE, N., BEL, S., GAUNT, S.J., AURRAND-LIONS, M., PEARCE, J., FISHER, A., and DJABALI, M. (1997). Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. Development 124, 721-729.
11. CZERMIN, B., MELFI, R., MCCABE, D., SEITZ, V., IMHOF, A., and PIRROTTA, V. (2002). Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111, 185-196.
12. DAHIYA, A., WONG, S., GONZALO, S., GAVIN, M., and DEAN, D.C. (2001). Linking the Rb and polycomb pathways. Mol. Cell 8, 557-569.
13. DEL MAR LORENTE, M., MARCOS-GUTIERREZ, C., PEREZ, C., SCHOORLEMMER, J., RAMIREZ, A., MAGIN, T., and VIDAL, M. (2000). Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development 127, 5093-5100.
14. DELLINO, G.I., SCHWARTZ, Y.B., FARKAS, G., MCCABE, D., ELGIN, S.C., and PIRROTTA, V. (2004). Polycomb silencing blocks transcription initiation. Mol. Cell 13, 887-893.
15. DIMRI, G.P., MARTINEZ, J.L., JACOBS, J.J., KEBLUSEK, P., ITAHANA, K., VAN LOHUIZEN, M., CAMPISI, J., WAZER, D.E., and BAND, V. (2002). The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62, 4736-4745.
16. ERHARDT, S., SU, I.H., SCHNEIDER, R., BARTON, S., BANNISTER, A.J., PEREZ-BURGOS, L., JENUWEIN, T., KOUZARIDES, T., TARAKHOVSKY, A., and SURANI, M.A. (2003). Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 130, 4235-4248.
17. FAUST, C., LAWSON, K.A., SCHORK, N.J., THIEL, B., and MAGNUSON, T. (1998). The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo. Development 125, 4495-4506.
18. FRANCIS, N.J., and KINGSTON, R.E. (2001). Mechanisms of transcriptional memory. Nat. Rev. Mol. Cell. Biol. 2, 409-421.
19. GIL, J., BERNARD, D., MARTINEZ, D., and BEACH, D. (2004). Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6, 67-72.
20. HAUPT, Y., ALEXANDER, W.S., BARRI, G., KLINKEN, S.P., and ADAMS, J.M. (1991). Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65, 753-763.
21. ITAHANA, K., ZOU, Y., ITAHANA, Y., MARTINEZ, J.L., BEAUSEJOUR, C., JACOBS, J.J., VAN LOHUIZEN, M., BAND, V., CAMPISI, J., and DIMRI, G.P. (2003). Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell Biol. 23, 389-401.
22. JACOBS, J.J., KIEBOOM, K., MARINO, S., DEPINHO, R.A., and VAN LOHUIZEN, M. (1999a). The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168.
23. JACOBS, J.J., SCHEIJEN, B., VONCKEN, J.W., KIEBOOM, K., BERNS, A., and VAN LOHUIZEN, M. (1999b). Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690.
24. JENUWEIN, T., and ALLIS, C.D. (2001). Translating the histone code. Science 293, 1074-1080.
25. KAJIUME, T., NINOMIYA, Y., ISHIHARA, H., KANNO, R., and KANNO, M. (2004). Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp. Hematol. 32, 571-578.
26. KANNO, M., HASEGAWA, M., ISHIDA, A., ISONO, K., and TANIGUCHI, M. (1995). mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J. 14, 5672-5678.
27. KATOH-FUKUI, Y., TSUCHIYA, R., SHIROISHI, T., NAKAHARA, Y., HASHIMOTO, N., NOGUCHI, K., and HIGASHINAKAGAWA, T. (1998). Male-to-female sex reversal in M33 mutant mice. Nature 393, 688-692.
28. KIM, J.Y., SAWADA, A., TOKIMASA, S., ENDO, H., OZONO, K., HARA, J., and TAKIHARA, Y. (2004). Defective long-term repopulating ability in hematopoietic stem cells lacking the Polycomb-group gene rae28. Eur. J. Haematol. 73, 75-84.
29. KIRMIZIS, A., BARTLEY, S.M., and FARNHAM, P.J. (2003). Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol. Cancer Ther. 2, 113-121.
30. KIRMIZIS, A., BARTLEY, S.M., KUZMICHEV, A., MARGUERON, R., REINBERG, D., GREEN, R., and FARNHAM, P.J. (2004). Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18, 1592-1605.
31. KLEER, C.G., CAO, Q., VARAMBALLY, S., SHEN, R., OTA, I., TOMLINS, S.A., GHOSH, D., SEWALT, R.G., OTTE, A.P., HAYES, D.F., et al. (2003). EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100, 11606-11611.
32. KRANC, K.R., BAMFORTH, S.D., BRAGANCA, J., NORBURY, C., VAN LOHUIZEN, M., and BHATTACHARYA, S. (2003). Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol. Cell Biol. 23, 7658-7666.
33. KUZMICHEV, A., JENUWEIN, T., TEMPST, P., and REINBERG, D. (2004). Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14, 183-193.
34. KUZMICHEV, A., NISHIOKA, K., ERDJUMENT-BROMAGE, H., TEMPST, P., and REINBERG, D. (2002). Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16, 2893-2905.
35. LESSARD, J., and SAUVAGEAU, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260.
36. LESSARD, J., BABAN, S., and SAUVAGEAU, G. (1998). Stage-specific expression of polycomb group genes in human bone marrow cells. Blood 91, 1216-1224.
37. LESSARD, J., SCHUMACHER, A., THORSTEINSDOTTIR, U., VAN LOHUIZEN, M., MAGNUSON, T., and SAUVAGEAU, G. (1999). Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev. 13, 2691-2703.
38. LEUNG, C., LINGBEEK, M., SHAKHOVA, O., LIU, J., TANGER, E., SAREMASLANI, P., VAN LOHUIZEN, M., and MARINO, S. (2004). Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337-341.
39. LOWE, S.W., and SHERR, C.J. (2003). Tumor suppression by Ink4a-Arf: Progress and puzzles. Curr. Opin. Genet. Dev. 13, 77-83.
40. LUND, A.H., and VAN LOHUIZEN, M. (2004). Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol. 16, 239-246.
41. MAGER, J., MONTGOMERY, N.D., DE VILLENA, F.P., and MAGNUSON, T. (2003). Genome imprinting regulated by the mouse Polycomb group protein Eed. Nat. Genet. 33, 502-507.
42. MATSUO, F., YANO, K., SAITO, H., MOROTOMI, K., KATO, M., YOSHIMOTO, M., KASUMI, F., AKIYAMA, F., SAKAMOTO, G., and MIKI, Y. (2002). Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines. Breast Cancer 9, 33-38.
43. MIN, J., ZHANG, Y., and XU, R.M. (2003). Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. Genes Dev. 17, 1823-1828.
44. MOLOFSKY, A.V., PARDAL, R., IWASHITA, T., PARK, I.K., CLARKE, M.F., and MORRISON, S.J. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967.
45. MULHOLLAND, N.M., KING, I.F., and KINGSTON, R.E. (2003). Regulation of Polycomb group complexes by the sequence-specific DNA binding proteins Zeste and GAGA. Genes Dev. 17, 2741-2746.
46. MULLER, H., BRACKEN, A.P., VERNELL, R., MORONI, M.C., CHRISTIANS, F., GRASSILLI, E., PROSPERINI, E., VIGO, E., OLINER, J.D., and HELIN, K. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285.
47. MULLER, J., HART, C.M., FRANCIS, N.J., VARGAS, M.L., SENGUPTA, A., WILD, B., MILLER, E.L., O'CONNOR, M.B., KINGSTON, R.E., and SIMON, J.A. (2002). Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111, 197-208.
48. OGAWA, H., ISHIGURO, K., GAUBATZ, S., LIVINGSTON, D.M., and NAKATANI, Y. (2002). A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in GO cells. Science 296, 1132-1136.
49. OHTA, H., SAWADA, A., KIM, J.Y., TOKIMASA, S., NISHIGUCHI, S., HUMPHRIES, R.K., HARA, J., and TAKIHARA, Y. (2002). Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J. Exp. Med. 195, 759-770.
50. OTTE, A.P., and KWAKS, T.H. (2003). Gene repression by Polycomb group protein complexes: A distinct complex for every occasion? Curr. Opin. Genet. Dev. 13, 448-454.
51. PARK, I.K., QIAN, D., KIEL, M., BECKER, M.W., PIHALJA, M., WEISSMAN, I.L., MORRISON, S.J., and CLARKE, M.F. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305.
52. PASINI, D., BRACKEN, A.P., and HELIN, K. (2004). Polycomb group proteins in cell cycle progression and cancer. Cell Cycle 3, 396-400.
53. POUX, S., MELFI, R., and PIRROTTA, V. (2001). Establishment of Polycomb silencing requires a transient interaction between PC and ESC. Genes Dev. 15, 2509-2514.
54. RAAPHORST, F.M., VAN KEMENADE, F.J., BLOKZIJL, T., FIERET, E., HAMER, K.M., SATIJN, D.P., OTTE, A.P., and MEIJER, C.J. (2000). Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol. 157, 709-715.
55. RAAPHORST, F.M., MEIJER, C.J., and OTTE, A.P. (2002). Correspondence re: S. Bea et al., BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61, 2409-2412, 2001. Cancer Res 62, 618-619.
56. RAAPHORST, F.M., MEIJER, C.J., and OTTE, A.P. (2002). Correspondence re: S. Bea et al., BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61, 2409-2412, 2001. Cancer Res 62, 618-619.
57. RAAPHORST, F.M., MEIJER, C.J., FIERET, E., BLOKZIJL, T., MOMMERS, E., BUERGER, H., PACKEISEN, J., SEWALT, R.A., OTTE, A.P., and VAN DIEST, P.J. (2003). Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 5, 481-488.
58. REYA, T., MORRISON, S.J., CLARKE, M.F., and WEISSMAN, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
59. RHODES, D.R., SANDA, M.G., OTTE, A.P., CHINNAIYAN, A.M., and RUBIN, M.A. (2003). Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J. Natl. Cancer Inst. 95, 661-668.
60. RINCHIK, E.M., and CARPENTER, D.A. (1993). N-ethyl-N-nitrosourea-induced prenatally lethal mutations define at least two complementation groups within the embryonic ectoderm development (eed) locus in mouse chromosome 7. Mamm. Genome 4, 349-353.
61. RINGROSE, L., REHMSMEIER, M., DURA, J.M., and PARO, R. (2003). Genome-wide prediction of Polycomb/Trithorax response elements in Drosophila melanogaster. Dev. Cell 5, 759-771.
62. SATIJN, D.P., and OTTE, A.P. (1999). RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity. Mol. Cell Biol. 19, 57-68.
63. SATIJN, D.P., OLSON, D.J., VAN DER VLAG, J., HAMER, K.M., LAMBRECHTS, C., MASSELINK, H., GUNSTER, M.J., SEWALT, R.G., VAN DRIEL, R., and OTTE, A.P. (1997). Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis. Mol. Cell Biol. 17, 6076-6086.
64. SATIJN, D.P., HAMER, K.M., DEN BLAAUWEN, J., and OTTE, A.P. (2001). The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos. Mol. Cell Biol. 21, 1360-1369.
65. SCHOORLEMMER, J., MARCOS-GUTIERREZ, C., WERE, F., MARTINEZ, R., GARCIA, E., SATIJN, D.P., OTTE, A.P., and VIDAL, M. (1997). Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain. EMBO J. 16, 5930-5942.
66. SEWALT, R.G., VAN DER VLAG, J., GUNSTER, M.J., HAMER, K.M., DEN BLAAUWEN, J.L., SATIJN, D.P., HENDRIX, T., VAN DRIEL, R., and OTTE, A.P. (1998). Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes. Mol. Cell Biol. 18, 3586-3595.
67. SEWALT, R.G., LACHNER, M., VARGAS, M., HAMER, K.M., DEN BLAAUWEN, J.L., HENDRIX, T., MELCHER, M., SCHWEIZER, D., JENUWEIN, T., and OTTE, A.P. (2002). Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins. Mol. Cell Biol. 22, 5539-5553.
68. SHARPLESS, N.E., and DEPINHO, R.A. (1999). The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9, 22-30.
69. SHARPLESS, N.E., and DEPINHO, R.A. (2004). Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160-168.
70. SHERR, C.J. (2001). The INK4a/ARF network in tumor suppression. Nat. Rev. Mol. Cell Biol. 2, 731-737.
71. SILVA, J., MAK, W., ZVETKOVA, I., APPANAH, R., NESTEROVA, T.B., WEBSTER, Z., PETERS, A.H., JENUWEIN, T., OTTE, A.P., and BROCKDORFF, N. (2003). Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev. Cell 4, 481-495.
72. SIMON, J.A. (2003). Polycomb group proteins. Curr. Biol. 13, R79-R80.
73. SMITH, K.S., CHANDA, S.K., LINGBEEK, M., ROSS, D.T., BOTSTEIN, D., VAN LOHUIZEN, M., and CLEARY, M.L. (2003). Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol. Cell 12, 393-400.
74. SUZUKI, M., MIZUTANI-KOSEKI, Y., FUJIMURA, Y., MIYAGISHIMA, H., KANEKO, T., TAKADA, Y., AKASAKA, T., TANZAWA, H., TAKIHARA, Y., NAKANO, M., MASUMOTO, H., VIDAL, M., ISONO, K., and KOSEKI, H. (2002). Involvement of the Polycomb-group gene RingIB in the specification of the anterior-posterior axis in mice. Development 129, 4171-4183.
75. TAKIHARA, Y., TOMOTSUNE, D., SHIRAI, M., KATOH-FUKUI, Y., NISHII, K., MOTALEB, M.A., NOMURA, M., TSUCHIYA, R., FUJITA, Y., SHIBATA, Y., et al. (1997). Targeted disruption of the mouse homologue of the Drosophila polyhomeotic gene leads to altered anteroposterior patterning and neural crest defects. Development 124, 3673-3682.
76. TETSU, O., ISHIHARA, H., KANNO, R., KAMIYASU, M., INOUE, H., TOKUHISA, T., TANIGUCHI, M., and KANNO, M. (1998). mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25. Immunity 9, 439-448.
77. TOKIMASA, S., OHTA, H., SAWADA, A., MATSUDA, Y., KIM, J.Y., NISHIGUCHI, S., HARA, J., and TAKIHARA, Y. (2001). Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage. Exp. Hematol. 29, 93-103.
78. TOMOTSUNE, D., TAKIHARA, Y., BERGER, J., DUHL, D., JOO, S., KYBA, M., SHIRAI, M., OHTA, H., MATSUDA, Y., HONDA, B.M., et al. (1999). A novel member of murine Polycomb-group proteins, sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28/mph1 in vitro. Differentiation 65, 229-239.
79. TRIMARCHI, J.M., FAIRCHILD, B., WEN, J., and LEES, J.A. (2001). The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 98, 1519-1524.
80. VAN DER LUGT, N.M., DOMEN, J., LINDERS, K., VAN ROON, M., ROBANUS-MAANDAG, E., TE RIELE, H., VAN DER VALK, M., DESCHAMPS, J., SOFRONIEW, M., VAN LOHUIZEN, M., et al. (1994). Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8, 757-769.
81. VAN DER VLAG, J., and OTTE, A.P. (1999). Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat. Genet. 23, 474-478.
82. VAN KEMENADE, F.J., RAAPHORST, F.M., BLOKZIJL, T., FIERET, E., HAMER, K.M., SATIJN, D.P., OTTE, A.P., and MEIJER, C.J. (2001). Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97, 3896-3901.
83. VAN LOHUIZEN, M., VERBEEK, S., SCHEIJEN, B., WIENTJENS, E., VAN DER GULDEN, H., and BERNS, A. (1991). Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65, 737-752.
84. VAN LOHUIZEN, M., TIJMS, M., VONCKEN, J.W., SCHUMACHER, A., MAGNUSON, T., and WIENTJENS, E. (1998). Interaction of mouse polycomb-group (Pc-G) proteins Enx1 and Enx2 with Eed: Indication for separate Pc-G complexes. Mol. Cell Biol. 18, 3572-3579.
85. VARAMBALLY, S., DHANASEKARAN, S.M., ZHOU, M., BARRETTE, T.R., KUMAR-SINHA, C., SANDA, M.G., GHOSH, D., PIENTA, K.J., SEWALT, R.G., OTTE, A.P., et al. (2002). The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629.
86. VISSER, H.P., GUNSTER, M.J., KLUIN-NELEMANS, H.C., MANDERS, E.M., RAAPHORST, F.M., MEIJER, C.J., WILLEMZE, R., and OTTE, A.P. (2001). The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br. J. Haematol. 112, 950-958.
87. VONCKEN, J.W., ROELEN, B.A., ROEFS, M., DE VRIES, S., VERHOEVEN, E., MARINO, S., DESCHAMPS, J., and VAN LOHUIZEN, M. (2003). Rnf2 (Ring1b) deficiency causes gastralation arrest and cell cycle inhibition. Proc. Natl. Acad. Sci. USA 100, 2468-2473.
88. VONLANTHEN, S., HEIGHWAY, J., ALTERMATT, H.J., GUGGER, M., KAPPELER, A., BORNER, M.M., VAN LOHUIZEN, M., and BETTICHER, D.C. (2001). The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84, 1372-1376.
89. WANG, J., MAGER, J., SCHNEDIER, E., and MAGNUSON, T. (2002). The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. Mamm Genome 13, 493-503.
90. WEINMANN, A.S., BARTLEY, S.M., ZHANG, T., ZHANG, M.Q., and FARNHAM, P.J. (2001). Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell Biol. 21, 6820-6832.
91. YAMAMOTO, K., SONODA, M., INOKUCHI, J., SHIRASAWA, S., and SASAZUKI, T. (2004). Polycomb group suppressor of zeste 12 links heterochromatin protein 1alpha and enhancer of zeste 2. J. Biol. Chem. 279, 401-406.